Breast cancer in lupus

Baquet, 2008, Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology, J Natl Med Assoc, 100, 480 Gadalla, 2009, Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case–control study, Br J Cancer, 100, 817, 10.1038/sj.bjc.6604906 Willett, 2004, Nongenetic factors in the causation of breast cancer, 223 Salazar-Onfray, 2007, Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape, Cytokine Growth Factor Rev, 18, 171, 10.1016/j.cytogfr.2007.01.015 Böhm, 2003, Disruption of the cytoskeleton after apoptosis induction by autoantibodies, Autoimmunity, 36, 183, 10.1080/0891693031000105617 Böhm, 2004, Apoptosis: the link between autoantibodies and leuko-/lymphocytopenia in patients with lupus erythematosus, Scand J Rheumatol, 33, 409, 10.1080/03009740410006907 Böhm, 2005, Nuclear-targeting autoantibodies induced nuclear PARP cleavage accompanied by more pronounced decrease of peripheral white blood cells than Ro/SSA and La/SSB antigen- targeting autoantibodies, J Clin Immunol, 25, 99, 10.1007/s10875-005-2815-1 Böhm, 2007, IgG deposits in patients with both malignancies and lupus erythematosus, Clin Rheumatol, 26, 1877, 10.1007/s10067-007-0597-y Sweeney, 1995, Risk of malignancy in women with systemic lupus erythematosus, J Rheumatol, 22, 1478 Abu-Shakra, 1996, Malignancy in systemic lupus erythematosus, Arthritis Rheum, 39, 1050, 10.1002/art.1780390625 Menon, 1993, The association of malignancy with SLE: an analysis of 150 patients under long-term review, Lupus, 2, 177, 10.1177/096120339300200309 Lopez Dupla, 1993, Malignancy in systemic lupus erythematosus: a report of five cases in a series of 96 patients, Lupus, 2, 377, 10.1177/096120339300200608 Bernatsky, 2005, An international cohort study of cancer in systemic lupus erythematosus, Arthritis Rheum, 52, 1481, 10.1002/art.21029 Bernatsky, 2004, Breast cancer stage at time of detection in women with systemic lupus erythematosus, Lupus, 13, 469, 10.1191/0961203304lu1008xx Kontos, 2008, Systemic lupus erythematosus and breast cancer, Breast J, 14, 81, 10.1111/j.1524-4741.2007.00520.x Greer, 1989, Incomplete lupus erythematosus, Arch Intern Med, 149, 2473, 10.1001/archinte.1989.00390110061013 Vilá, 2000, Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus, Lupus, 9, 110, 10.1191/096120300678828073 Tan, 1982, The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 25, 1271, 10.1002/art.1780251101 Hochberg, 1997, for the diagnostic and therapeutic criteria committee of the American college of rheumatology. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 40, 1725, 10.1002/art.1780400928 Ramsey-Goldman, 1998, Increased risk of malignancy in patients with systemic lupus erythematosus, J Invest Med, 46, 217 Sulkes, 1991, The infrequent association of systemic lupus erythematosus and solid tumors, Cancer, 68, 1389, 10.1002/1097-0142(19910915)68:6<1389::AID-CNCR2820680635>3.0.CO;2-Y Bhalla, 1993, Systemic lupus erythematosus and Hodgkin’s lymphoma, J Rheumatol, 20, 1316 Lugassy, 1992, Systemic lupus erythematosus and chronic lymphocytic leukemia: rare coexistence in three patients, with comments on pathogenesis, Leuk Lymphoma, 8, 243, 10.3109/10428199209054911 Munzert, 1997, Concomitant manifestation of systemic lupus erythematosus and low-grade non-Hodgkin’s lymphoma, Leukemia, 11, 1324, 10.1038/sj.leu.2400715 Castanet, 1995, Subacute cutaneous lupus erythematosus associated with Hodgkin’s disease, Clin Rheumatol, 14, 692, 10.1007/BF02207938 Schewach-Millet, 1988, Subacute cutaneous lupus erythematosus associated with breast carcinoma, J Am Acad Dermatol, 19, 406, 10.1016/S0190-9622(88)70188-7 Miyagawa, 1996, Development of squamous cell carcinoma in chronic discoid lupus erythematosus: a report of two patients with anti-Ro/SSA antibodies, Lupus, 5, 630, 10.1177/096120339600500614 Juranic, 2008, Humoral immunoreactivity to gliadin and to tissue transglutaminase is present in some patients with multiple myeloma, BMC Immunol, 9, 22, 10.1186/1471-2172-9-22 Tanaka, 2010, Dynamic movements of Ro52 cytoplasmic bodies along microtubules, Histochem Cell Biol, 133, 273, 10.1007/s00418-009-0669-y Reed, 2009, Ro 60 functions as a receptor for beta(2)-glycoprotein I on apoptotic cells, Arthritis Rheum, 60, 860, 10.1002/art.24361